Know Labs (OTCMKTS:KNWN) and Abaxis (NASDAQ:ABAX) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.
Earnings and Valuation
This table compares Know Labs and Abaxis’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Know Labs||$4.87 million||10.53||-$3.90 million||N/A||N/A|
This table compares Know Labs and Abaxis’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Abaxis pays an annual dividend of $0.72 per share and has a dividend yield of 0.9%. Know Labs does not pay a dividend. Abaxis has raised its dividend for 3 consecutive years.
Insider & Institutional Ownership
90.2% of Abaxis shares are owned by institutional investors. 27.3% of Know Labs shares are owned by company insiders. Comparatively, 4.3% of Abaxis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This is a summary of current recommendations for Know Labs and Abaxis, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Abaxis has a consensus target price of $58.33, suggesting a potential downside of 29.72%. Given Abaxis’ higher probable upside, analysts clearly believe Abaxis is more favorable than Know Labs.
Abaxis beats Know Labs on 7 of the 9 factors compared between the two stocks.
About Know Labs
Know Labs, Inc., develops, markets, and sells proprietary technology solution for identification, authentication, and diagnosis. It offers ChromaID Lab Kit, which scans and identifies solid surfaces targeting various markets, including commercial paint manufacturers, pharmaceutical equipment manufacturers, process control companies, currency paper and ink manufacturers, security cards, cosmetic companies, scanner manufactures, and food processing companies. The company, through its subsidiary TransTech Systems, Inc., distributes products for employee and personnel identification. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is based in Seattle, Washington.
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care to provide rapid blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan profiles, which are packaged as single-use plastic veterinary reagent discs; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results; VetScan UA, a urinalysis solution; and VetScan SA, which is designed to perform urine microscopy. Further, it provides VetScan rapid tests for the detection of various diseases, as well as sells products developed through its patented Orbos discrete lyophilization process to companies for other applications. The company sells its products through direct sales force and independent distributors. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.
Receive News & Ratings for Know Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Know Labs and related companies with MarketBeat.com's FREE daily email newsletter.